Drugs / Hexyon
Regulatory milestones approvals, filings & regulatory actions · 2 recorded
| Milestone | Jurisdiction | Brand | Indication | Date | Sentence it was read from |
|---|---|---|---|---|---|
| Approved | EU (EMA) | Hexyon | — | 2013-04-17 | europa.eu ↗ |
| Refused (EMA) | EU (EMA) | Hexyon | — | 2013-02-22 | europa.eu ↗ |
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 3 | NCT06975878 Background | May 2025 → Aug 2027 expected | — | Sanofi | Active not recruiting | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Hexyon | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06975878 ↗ |
| Modality | Vaccine | “Biological: Hexyon vaccine” NCT06975878 ↗ |
| Route | Intramuscular | “Route of administration:Intramuscular” NCT06975878 ↗ |